These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

993 related articles for article (PubMed ID: 28161507)

  • 1. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
    Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
    Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.
    Park NR; Cha JH; Jang JW; Bae SH; Jang B; Kim JH; Hur W; Choi JY; Yoon SK
    Biochem Biophys Res Commun; 2016 Sep; 477(4):568-574. PubMed ID: 27320862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma.
    Modi SJ; Kulkarni VM
    Eur J Med Chem; 2020 Dec; 207():112851. PubMed ID: 33002846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-Mesenchymal Transition (EMT) Induced by TGF-β in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism.
    Soukupova J; Malfettone A; Bertran E; Hernández-Alvarez MI; Peñuelas-Haro I; Dituri F; Giannelli G; Zorzano A; Fabregat I
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression.
    Rani B; Malfettone A; Dituri F; Soukupova J; Lupo L; Mancarella S; Fabregat I; Giannelli G
    Cell Death Dis; 2018 Mar; 9(3):373. PubMed ID: 29515105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transforming growth factor-beta (TGF-β) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells.
    Caja L; Bertran E; Campbell J; Fausto N; Fabregat I
    J Cell Physiol; 2011 May; 226(5):1214-23. PubMed ID: 20945437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint molecules are regulated by transforming growth factor (TGF)-
    Shrestha R; Bridle KR; Crawford DHG; Jayachandran A
    Int J Med Sci; 2021; 18(12):2466-2479. PubMed ID: 34104078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/ syndecan-1/TGF-β autocrine loop.
    Zeng Y; Yao X; Chen L; Yan Z; Liu J; Zhang Y; Feng T; Wu J; Liu X
    Oncotarget; 2016 Sep; 7(39):63324-63337. PubMed ID: 27556509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
    Wang J; Fan Z; Li J; Yang J; Liu X; Cheng J
    Bioengineered; 2021 Dec; 12(1):3566-3577. PubMed ID: 34281492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma.
    Giannelli G; Bergamini C; Fransvea E; Sgarra C; Antonaci S
    Gastroenterology; 2005 Nov; 129(5):1375-83. PubMed ID: 16285938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling.
    Yang G; Liang Y; Zheng T; Song R; Wang J; Shi H; Sun B; Xie C; Li Y; Han J; Pan S; Lan Y; Liu X; Zhu M; Wang Y; Liu L
    Cancer Lett; 2016 Aug; 378(2):80-6. PubMed ID: 27177473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoviolanthin Extracted from
    Xing S; Yu W; Zhang X; Luo Y; Lei Z; Huang D; Lin J; Huang Y; Huang S; Nong F; Zhou C; Wei G
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29882900
    [No Abstract]   [Full Text] [Related]  

  • 15. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
    Liu ZH; Zhang YF; Xu ZD; Z H L; Y F Z; Z D X
    J BUON; 2018; 23(6):1717-1724. PubMed ID: 30610799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HAb18G/CD147 is involved in TGF-β-induced epithelial-mesenchymal transition and hepatocellular carcinoma invasion.
    Ru NY; Wu J; Chen ZN; Bian H
    Cell Biol Int; 2015 Jan; 39(1):44-51. PubMed ID: 25044444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma.
    Ou H; Chen Z; Xiang L; Fang Y; Xu Y; Liu Q; Hu Z; Li X; Huang Y; Yang D
    Cancer Sci; 2019 Apr; 110(4):1169-1182. PubMed ID: 30677195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
    Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
    Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
    Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
    Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.
    Zhong M; Zhong C; Cui W; Wang G; Zheng G; Li L; Zhang J; Ren R; Gao H; Wang T; Li X; Che J; Gohda E
    BMC Cancer; 2019 May; 19(1):439. PubMed ID: 31088527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.